top of page

PME

Pro Medicus Ltd

Health Care Technology

·

Healthcare

54

comments

23

fund managers

past 90 days

About Pro Medicus Ltd

Pro Medicus Ltd. develops and supplies medical imaging software and Radiology Information Systems (RIS) for hospitals. Founded in 1983 by Sam Aaron Hupert and Anthony Barry Hall, the company is headquartered in Richmond, Australia. Its primary product suite includes the Visage 7 and Visage RIS platforms. Pro Medicus operates globally, with core market segments across Australia, Europe, and North America. The firm specializes in providing advanced health imaging informatics and related services, delivering scalable software solutions designed to support clinical workflow efficiency and enterprise-wide diagnostic imaging requirements for healthcare providers.

Commentary Volume

54

Comments

23

Fund managers

0

Past 90 days

SOURCE

ACTION

COMMENT PREVIEW

FUND MANAGER

DATE

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Loading...

.

​Loading...

Loading...

Loading...

Loading...

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Report a problem

Loading...

.

Loading...

Loading...

Loading...

Loading...

14 Mar 2025

ic

Ipsum Capital

"Lorem ipsum dolor sit amet...

Q4 Letter

14 Mar 2025

ic

Dolor Investments

"Lorem ipsum dolor sit amet...

Q4 Letter

🔒 21 more comments from 10 sources

Unlock full access

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Commentary

Sector

Healthcare

Market cap

$13B

Fund managers

23 managers

First covered

30 Jan 2024

Last updated

30 Apr 2026

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Reminder

The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Frequently asked questions about Pro Medicus Ltd (ASX:PME)

Frequently asked questions

Who is investing in Pro Medicus Ltd (ASX:PME)?

Fund managers including Ausbil Investment Management, Oracle Advisory Group, Maple-Brown Abbott, Yarra Capital Management, Ten Cap, ELM Responsible Investments, Kardinia Capital, Antares Capital, First Sentier Investors, Hyperion Asset Management, Lakehouse Capital, Selector Funds Management, Glennon Small Companies, Infinity Asset Management, LHC Capital, Wilson Asset Management, Firetrail Investments, Solaris Investment Management, SG Hiscock & Company, Naos Asset Management, Forager Funds, TMS Capital and Ellerston Capital have invested in Pro Medicus Ltd (ASX:PME).

What is the short interest in Pro Medicus Ltd (ASX:PME)?

The short interest in Pro Medicus Ltd (ASX:PME) is 1.35% which makes it the 184th most shorted stock on the ASX. Of the 104.5M shares that Pro Medicus Ltd has on issue, 1.4M have been sold short.

What does Pro Medicus Ltd (ASX:PME) do?

Pro Medicus Ltd. develops and supplies medical imaging software and Radiology Information Systems (RIS) for hospitals. Founded in 1983 by Sam Aaron Hupert and Anthony Barry Hall, the company is headquartered in Richmond, Australia. Its primary product suite includes the Visage 7 and Visage RIS platforms. Pro Medicus operates globally, with core market segments across Australia, Europe, and North America. The firm specializes in providing advanced health imaging informatics and related services, delivering scalable software solutions designed to support clinical workflow efficiency and enterprise-wide diagnostic imaging requirements for healthcare providers.

bottom of page